T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers Meeting Abstract

  

Authors:	Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
Abstract Title:	T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Meeting Title:	AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Journal Title:	Molecular Cancer Therapeutics
Volume:	18
Issue:	12 Suppl.
Meeting Dates:	2019 Oct 26-30
Meeting Location:	Boston, MA
ISSN:	1535-7163
Publisher:	American Association for Cancer Research
Date Published:	2019-12-01
Language:	English
ACCESSION:	WOS:000510047200371
DOI:	10.1158/1535-7163.Targ-19-cn01-03
PROVIDER:	wos
Notes:	Meeting Abstract: CN01-03 -- Source: Wos